← Interstellar Blends
Pathway

Muscle glucose uptake

The Door Sugar Walks Through

1 blend on this site modulates it.

Glucose does not diffuse into muscle. It is carried, and GLUT4 is the carrier. At rest it waits in vesicles inside the cell; when insulin or contraction signals arrive, those vesicles fuse with the membrane and the door opens. More GLUT4 at the surface means more glucose leaving the bloodstream and entering tissue that will burn it. Two routes converge here. insulin signals through PI3K and Akt. Energy stress signals through AMPK — and that second route is why exercise lowers blood glucose in people whose insulin signaling is already impaired. Four human meta-analyzes covering more than eleven thousand participants support the AMPK arm, and the effect scales with baseline rather than dose: the worse the starting glucose, the larger the movement. The relationship is sufficient, not necessary. AMPK activation is enough to move glucose disposal; it is not the only thing that can. Berberine's a-grade evidence sits on the outcome — HbA1c and fasting glucose — while its contribution here is the mechanism that explains it.

In depth

GLUT4 is the transporter muscle moves to its surface to take glucose out of the blood — the step where disposal actually happens.

What drives it

Energy sensing increases it.

Sufficiency and necessity are separate claims, and these two trials test them separately. Heliyon 2022 (PMC9593205): "AMPK activation is sufficient to increase skeletal muscle glucose uptake and glycogen synthesis but is not…. PMID 34561225 Verbatim: “We conclude that AMPK activation increases cardiac muscle glucose uptake through translocation of GLUT-4 via a pathway that is independent of PI3K”. doi 10.1152/ajpheart.1999.277.2.H643 · PMID 34561225 · PMC9593205

Beta-3 receptor signaling increases it.

activation of the beta3-AR with the selective beta3-AR agonist mirabegron increases human BAT metabolic activity, whole-body energy expenditure, as well as plasma FFA and BAT glucose uptake. PMID 31961826

What it drives

It reduces Blood-sugar support.

Gain of function (JCI 1995, euglycemic-hyperinsulinemic clamp in conscious mice): whole-body glucose disposal 70% higher basal, 81% and 54% higher at submaximal and maximal insulin. Fed glucose 172±7 vs…. 10.1172/JCI117673. doi 10.1172/JCI117673

Blends that modulate it

Each blend page names this pathway and carries the study behind its claim.

Thermo (Thermogenic Disposal) →

See it on the map

Open the causal map to follow this pathway upstream and downstream, arrow by arrow, each with its study.

All 567 pathways · All botanicals

Share𝕏  X●  Facebook◉  Reddit✈  WhatsApp✉  Email